Researchers funded by the Type 1 Diabetes Grand Challenge have developed a new insulin–glucagon molecule, which could reduce dangerous drops in blood glucose.

The first ever immunotherapy for type 1 diabetes is critical for keeping the UK at the forefront of diabetes care, a top consultant has said.

The Obesity & Weight Management Alliance has announced a nationwide call for poster submissions ahead of its 2026 conference series, which promises to be the most extensive yet.

A unique platform that uses the universal language of music to help people better understand diabetes and other healthcare concepts has been launched to mark World Diabetes Day.  

Registrations are now open for the 2026 Obesity & Weight Management Alliance Conferences – returning for a third consecutive year with an expanded format to meet growing demand from UK healthcare professionals.

The European Association for the Study of Diabetes (EASD) is urging health systems to introduce population-wide screening for type 1 diabetes in young children, starting between ages two and four.

The digital health and medical device company behind the CamAPS FX app has announced the launch of its iPhone companion feature, enabling iPhone users to remotely monitor glucose and insulin data for people living with type 1 diabetes. 

GIRFT is inviting NHS Trusts to join a new national pilot designed to improve insulin management for people living with diabetes in the community, while also creating a more efficient service for the NHS.

GLP-1 receptor agonist drugs protect against diabetic retinopathy – a common complication of diabetes that can lead to sight loss.

A new synthesis of global evidence finds that experiencing gestational diabetes during pregnancy is linked with a decline in intellectual function among mothers, and may increase the risk of autism spectrum disorder and attention-deficit/hyperactivity disorder (ADHD) in children. 

In adults with type 1 diabetes and obesity, low dose tirzepatide reduced their weight, HbA1c levels and insulin dose requirements, a clinical trial has demonstrated.

In women with type 2 diabetes, use of hormone replacement therapy (HRT) skin patches is not associated with a higher risk of blood clots or stroke.

New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) 2025 in Vienna shows that smoking increases the risk of type 2 diabetes, regardless of subtype.

Trend Diabetes has released a brand-new educational video “How to examine for lipohypertrophy,” delivered by Debbie Hicks, Chair of Trend Diabetes. 

As part of its ongoing commitment to improving access to innovative diabetes technology, Spirit Health has announced a CareSens Air Continuous Glucose Monitor (CGM) giveaway for healthcare professionals in the lead-up to World Diabetes Day on November 14.

A simple breath test could soon be a cheaper and quicker way to diagnose diabetes and pre-diabetes, thanks to a new device.

An innovative point-of-care diagnostics solutions provider has donated more than £40,000 worth of vital diabetes supplies to help people living with the condition in Sierra Leone.

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight.

Levemir® insulin, in both its Penfill® and Flexpen® presentations, is to be discontinued, with an anticipated supply end date of December 2026.